Protara Therapeutics, Inc.
TARA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001359931
No open-market purchases or sales by Protara Therapeutics, Inc. insiders were filed in the last 90 days; 119 institutions reported holding it in 13F filings for Q2 2026, worth $176.0M in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Protara Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- −1 vs. Q2 2024
- Shares held
- 10.4M
- +415.9K (+4.1%) vs. Q2 2024
- Total value
- $19.1M
- −$2.25M (−10.5%) vs. Q2 2024
- New holders
- 6
- 13 more added
- Sold out
- 7
- 7 more reduced
2 institutions that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TARA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 119 | $176.0M |
| Q1 2026 | 114 | $237.4M |
| Q4 2025 | 105 | $212.3M |
| Q3 2025 | 81 | $114.0M |
| Q2 2025 | 76 | $90.1M |
| Q1 2025 | 59 | $123.8M |
| Q4 2024 | 60 | $156.6M |
| Q3 2024 | 35 | $19.1M |
| Q2 2024 | 38 | $22.2M |
| Q1 2024 | 34 | $18.3M |
| Q4 2023 | 30 | $8.17M |
| Q3 2023 | 31 | $8.55M |
| Q2 2023 | 29 | $12.3M |
| Q1 2023 | 29 | $16.9M |
| Q4 2022 | 30 | $14.7M |
| Q3 2022 | 31 | $16.7M |
| Q2 2022 | 33 | $18.4M |
| Q1 2022 | 35 | $33.2M |
| Q4 2021 | 38 | $46.5M |
| Q3 2021 | 36 | $43.7M |
| Q2 2021 | 40 | $69.3M |
| Q1 2021 | 50 | $134.0M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Protara Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 373 | $0 | 0.00% | +373 | New |
| Advisor Group Holdings, Inc. | 100 | $183 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 366 | $670 | 0.00% | +217+145.6% | Added |
| Semmax Financial Advisors Inc. | 1,572 | $4.06K | 0.00% | +1,572 | New |
| Tower Research Capital LLC (TRC) | 2,783 | $5.09K | 0.00% | −1,236−30.8% | Reduced |
| Royal Bank of Canada | 3,500 | $6.00K | 0.00% | −2,802−44.5% | Reduced |
| UBS Group AG | 7,418 | $13.6K | 0.00% | +7,418 | New |
| Millennium Management LLC | 14,402 | $26.4K | 0.00% | +14,402 | New |
| Boothbay Fund Management, LLC | 17,398 | $31.8K | 0.00% | −2,793−13.8% | Reduced |
| Bank of New York Mellon Corp | 17,907 | $32.8K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 19,428 | $36.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 26,600 | $48.7K | 0.00% | 00.0% | Unchanged |
| CIBC World Markets Inc. | 28,000 | $51.0K | 0.00% | −9,000−24.3% | Reduced |
| Northern Trust Corp | 28,976 | $53.0K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 32,682 | $59.8K | 0.00% | +32,682 | New |
| Truist Financial Corp | 40,000 | $73.2K | 0.00% | +20,000+100.0% | Added |
| LPL Financial LLC | 46,000 | $84.2K | 0.00% | +2,000+4.5% | Added |
| Bridgeway Capital Management, LLC | 49,200 | $90.0K | 0.00% | +25,000+103.3% | Added |
| Marshall Wace, LLP | 77,351 | $141.6K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 116,977 | $214.1K | 0.00% | +116,977 | New |
| Two Sigma Advisers, LP | 151,618 | $277.5K | 0.00% | +71,100+88.3% | Added |
| Ikarian Capital, LLC | 155,712 | $285.0K | 0.09% | −25,000−13.8% | Reduced |
| Geode Capital Management, LLC | 170,040 | $311.2K | 0.00% | +29,514+21.0% | Added |
| Oppenheimer & Co Inc | 179,125 | $327.8K | 0.00% | +51,944+40.8% | Added |
| Two Sigma Investments, LP | 185,223 | $339.0K | 0.00% | +29,450+18.9% | Added |
| Renaissance Technologies LLC | 336,740 | $616.2K | 0.00% | +186,340+123.9% | Added |
| Baker Bros. Advisors LP | 536,832 | $982.4K | 0.01% | 00.0% | Unchanged |
| Velan Capital Investment Management LP | 574,000 | $1.05M | 1.14% | +94,000+19.6% | Added |
| Citadel Advisors LLC | 680,511 | $1.25M | 0.00% | +15,139+2.3% | Added |
| Vanguard Group Inc | 759,612 | $1.39M | 0.00% | +332,000+77.6% | Added |
| Boxer Capital, LLC | 811,627 | $1.49M | 0.07% | 00.0% | Unchanged |
| Woodline Partners LP | 851,567 | $1.56M | 0.01% | +751,566+751.6% | Added |
| StemPoint Capital LP | 942,857 | $1.73M | 0.52% | −41,256−4.2% | Reduced |
| Opaleye Management Inc. | 1,681,154 | $3.08M | 0.51% | −623,108−27.0% | Reduced |
| Ra Capital Management, L.P. | 1,900,000 | $3.48M | 0.04% | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −520,000−100.0% | Sold out |
| Privium Fund Management (UK) Ltd | 0 | $0 | 0.00% | −114,708−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −12,850−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −10,036−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −2,550−100.0% | Sold out |
| Wells Fargo & Company | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| CVI Holdings, LLC | – | – | – | – | Not filed |
| BlackRock Inc. | – | – | – | – | Not filed |